Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04088500
Title A Study of Combination Nivolumab and Ipilimumab Retreatment in Patients With Advanced Renal Cell Carcinoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb

renal cell carcinoma


Ipilimumab + Nivolumab

Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
Washington University School of Medicine in St. Louis WUSTL Saint Louis Missouri 63110-1002 United States Details
Local Institution Calgary Alberta T3B 3L1 Canada Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
BC Cancer Agency - Vancouver Centre Vancouver British Columbia V5Z 4E6 Canada Details
Atlantic Clinical Cancer Research Unit Halifax Nova Scotia B3H 1V7 Canada Details
Hamilton Health Sciences (HHS) - Juravinski Cancer Centre (JCC) Hamilton Ontario L8V 5C2 Canada Details
Toronto Sunnybrook Regional Cancer Ctr Toronto Ontario M4N 3M5 Canada Details
Local Institution Toronto Ontario M5G 2M9 Canada Details
Local Institution Montreal Quebec H2X 3E4 Canada Details
Local Institution - 0005 Montreal Quebec H3T 1E2 Canada Details
Local Institution Quebec City Quebec G2L 2Z3 Canada Details
Local Institution - 0006 Sherbrooke Quebec J1H 5N4 Canada Details
*Shaded cells indicate that there was no data available from for the field